Movement disorders induced by dopamine blocking agents

K. D. Sethi

Research output: Contribution to journalReview article

31 Citations (Scopus)

Abstract

Movement disorders are frequently due to dopamine blocking agents (DBAs) prescribed for psychiatric illnesses. DBAs are sometimes also prescribed inappropriately for other maladies. These drugs can cause a wide variety of involuntary movements, sometimes in combination. When these appear in the setting of psychiatric illnesses, the association is easy to recognize but the treatment remains a difficult problem. However, in other situations the diagnosis may be missed for extended periods of time, resulting in unnecessary diagnostic work-up and inappropriate therapy. The diagnosis depends on a compulsive drug history not only from the patient but also from patient's family, primary physician, and the pharmacist. The treatment options include removal of the offending agent or substitution with an atypical neuroleptic. Symptomatic treatments are varied and have an inconsistent effect on the movement disorders. Prevention remains the most important strategy.

Original languageEnglish (US)
Pages (from-to)59-68
Number of pages10
JournalSeminars in Neurology
Volume21
Issue number1
StatePublished - May 9 2001

Fingerprint

Dopamine Agents
Movement Disorders
Psychiatry
Dyskinesias
Family Physicians
Therapeutics
Pharmacists
Pharmaceutical Preparations
Antipsychotic Agents
History

Keywords

  • Antipsychotic drugs
  • Dopamine blocking agents
  • Drug-induced parkinsonism
  • Pathophysiology
  • Risk factors
  • Schizophrenia
  • Tardive dyskinesia
  • Treatment

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Movement disorders induced by dopamine blocking agents. / Sethi, K. D.

In: Seminars in Neurology, Vol. 21, No. 1, 09.05.2001, p. 59-68.

Research output: Contribution to journalReview article

Sethi, K. D. / Movement disorders induced by dopamine blocking agents. In: Seminars in Neurology. 2001 ; Vol. 21, No. 1. pp. 59-68.
@article{82840da44d72408784151c215f80d4db,
title = "Movement disorders induced by dopamine blocking agents",
abstract = "Movement disorders are frequently due to dopamine blocking agents (DBAs) prescribed for psychiatric illnesses. DBAs are sometimes also prescribed inappropriately for other maladies. These drugs can cause a wide variety of involuntary movements, sometimes in combination. When these appear in the setting of psychiatric illnesses, the association is easy to recognize but the treatment remains a difficult problem. However, in other situations the diagnosis may be missed for extended periods of time, resulting in unnecessary diagnostic work-up and inappropriate therapy. The diagnosis depends on a compulsive drug history not only from the patient but also from patient's family, primary physician, and the pharmacist. The treatment options include removal of the offending agent or substitution with an atypical neuroleptic. Symptomatic treatments are varied and have an inconsistent effect on the movement disorders. Prevention remains the most important strategy.",
keywords = "Antipsychotic drugs, Dopamine blocking agents, Drug-induced parkinsonism, Pathophysiology, Risk factors, Schizophrenia, Tardive dyskinesia, Treatment",
author = "Sethi, {K. D.}",
year = "2001",
month = "5",
day = "9",
language = "English (US)",
volume = "21",
pages = "59--68",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Movement disorders induced by dopamine blocking agents

AU - Sethi, K. D.

PY - 2001/5/9

Y1 - 2001/5/9

N2 - Movement disorders are frequently due to dopamine blocking agents (DBAs) prescribed for psychiatric illnesses. DBAs are sometimes also prescribed inappropriately for other maladies. These drugs can cause a wide variety of involuntary movements, sometimes in combination. When these appear in the setting of psychiatric illnesses, the association is easy to recognize but the treatment remains a difficult problem. However, in other situations the diagnosis may be missed for extended periods of time, resulting in unnecessary diagnostic work-up and inappropriate therapy. The diagnosis depends on a compulsive drug history not only from the patient but also from patient's family, primary physician, and the pharmacist. The treatment options include removal of the offending agent or substitution with an atypical neuroleptic. Symptomatic treatments are varied and have an inconsistent effect on the movement disorders. Prevention remains the most important strategy.

AB - Movement disorders are frequently due to dopamine blocking agents (DBAs) prescribed for psychiatric illnesses. DBAs are sometimes also prescribed inappropriately for other maladies. These drugs can cause a wide variety of involuntary movements, sometimes in combination. When these appear in the setting of psychiatric illnesses, the association is easy to recognize but the treatment remains a difficult problem. However, in other situations the diagnosis may be missed for extended periods of time, resulting in unnecessary diagnostic work-up and inappropriate therapy. The diagnosis depends on a compulsive drug history not only from the patient but also from patient's family, primary physician, and the pharmacist. The treatment options include removal of the offending agent or substitution with an atypical neuroleptic. Symptomatic treatments are varied and have an inconsistent effect on the movement disorders. Prevention remains the most important strategy.

KW - Antipsychotic drugs

KW - Dopamine blocking agents

KW - Drug-induced parkinsonism

KW - Pathophysiology

KW - Risk factors

KW - Schizophrenia

KW - Tardive dyskinesia

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0035028237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035028237&partnerID=8YFLogxK

M3 - Review article

C2 - 11346026

AN - SCOPUS:0035028237

VL - 21

SP - 59

EP - 68

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 1

ER -